Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03762642
Other study ID # 357-71
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 17, 2017
Est. completion date August 2, 2018

Study information

Verified date December 2018
Source King Abdulaziz University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Breast cancer is the most common cancer in women across the world, accounting for 25.2% of cancer cases among females and 14.7% of cancer-related deaths among females worldwide. The survival rates are markedly lower in the developing countries compared to developed countries, as well as the age at diagnosis. Core management of breast cancer includes surgical removal of the tumor either by breast-conserving surgery (BCS) or mastectomy (removal of the whole breast). Choosing between these two procedures may be influenced by factors that have yet to be studied in Saudi Arabia. The investigators aimed to determine the prevalence of BCS and mastectomy and the factors that may influence the choice of procedure. This retrospective study was carried out by reviewing the records of female breast cancer patients who underwent BCS or mastectomy at King Abdulaziz University Hospital between 2009 to June 2017, excluding those with metastasis (distant spread of the cancer) or recurrence. Using frequencies for the rate, and multivariate tests, the investigators analyzed different demographic, clinicopathological, and radiological factors to detect correlations with procedure choice.


Recruitment information / eligibility

Status Completed
Enrollment 335
Est. completion date August 2, 2018
Est. primary completion date August 2, 2018
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Female, diagnosed with breast cancer, underwent surgery on the breast tumor in King Abdulaziz University Hospital

Exclusion Criteria:

- Patients with metastatic breast cancer or recurrence of the cancer before the surgery

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Mastectomy
Removal of the whole breast
Breast-Conserving Surgery
Removal of the cancerous tissue only

Locations

Country Name City State
Saudi Arabia Faculty of Medicine Jeddah Mecca

Sponsors (1)

Lead Sponsor Collaborator
King Abdulaziz University

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of each of mastectomy and breast-conserving surgery The percentage of of patients who underwent each surgery 2009-2017
Secondary The relationship between the choice of procedure and the patients' age (in years) Statistical analysis using independent sample T-test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and the use of preoperative chemotherapy (also called "neoadjuvant chemotherapy") Statistical analysis using Chi-square test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and the tumor's laterality (right versus left breast cancer) Statistical analysis using Chi-square test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and the tumor's focality (whether it is composed of more than one mass) Statistical analysis using Chi-square test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and the tumor's centricity (whether it involves more than one quadrant of the breast) Statistical analysis using Chi-square test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and the tumor's size (in centimeters) Statistical analysis using independent sample T-test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and the tumor's stage (using the 7th "American Joint Committee on Cancer"'s staging guidelines) Statistical analysis using Chi-square test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and the tumor's histological grade (using the Nottingham Histologic Score system) Statistical analysis using Chi-square test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and the tumor's receptor status (whether it is positive for estrogen, progesterone, and/or human epidermal growth factor receptor 2) Statistical analysis using Chi-square test and binary logistic regression 2009-2017
Secondary The relationship between the choice of procedure and having preoperative magnetic resonance imaging of the breast and its findings Statistical analysis using Chi-square test and binary logistic regression 2009-2017
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Recruiting NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Recruiting NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A